We don't trust them, but we take their pills
I was cruising through a New York Times article about big drug companies and their image problems when I was stopped by some numbers that simply don’t compute.
It wasn’t the drug companies’ declining prestige that surprised me.
The Times cited all kinds of reasons: prices consistently higher than in other countries, safety concerns such as the Vioxx withdrawal, questions about antidepressants and hormone replacement therapies, more use of generics, and pervasive advertising that has gotten downright irritating.
The Times cited a poll taken las